XML 61 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies - License Agreement with Cardiff (Details)
6 Months Ended
Aug. 05, 2013
shares
Mar. 27, 2007
USD ($)
item
Jun. 30, 2018
USD ($)
Contribution Agreement      
Agreement      
Shares issued for assets (in shares) | shares 1,125,000    
Percentage of outstanding shares of common stock upon issuance 100.00%    
License Agreement | Cardiff      
Agreement      
Agreement termination notice (in days)   90 days  
Default or breach cure period   90 days  
Late payment period   1 month  
Number of occasions in 12 month period | item   2  
First written notice period   120 days  
Royalty threshold rate (as a percent)   30.00%  
Second written notice period   90 days  
Initial base payment made   $ 270,000  
BMS Agreement      
Agreement      
Initial base payment made   1,000,000  
Potential milestone payment   9,000,000  
Milestone payments made     $ 0
Milestone payment accrual     $ 0
BMS Agreement | Marketing FDA Approval      
Agreement      
Potential milestone payment   3,000,000  
BMS Agreement | Aggregate net sales equal to or greater than $125 million      
Agreement      
Potential milestone payment   $ 6,000,000